We recently published Jim Cramer Discussed AI “Mojo” & Commented On These 13 Stocks. Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the stocks discussed by Jim Cramer. Revolution Medicines, Inc.

Revolution Medicines announced a stunning survival benefit for its experimental drug in a Phase 3 pancreatic cancer study ...

Discover how Anneo Biotech is quietly leading India's probiotic revolution, building the future of preventive healthcare.

Massachusetts biopharma companies report that 90% of firms struggle to fill senior roles. A new leadership initiative aims to ...

This week on "The Readout LOUD," a pancreatic cancer breakthrough and new hope for an off-the-shelf CAR-T treatment in ...

Revolution Medicines stock surged more than 36% Monday—on pace for its largest one-day increase on record—after the ...

After Revolution Medicines’ drug candidate doubled survival in a Phase 3 pancreatic cancer study, the biotech is hoping to ...

In what looks to be the largest follow-on stock offering in biopharma history, US oncology company Revolution Medicines ...

Revolution Medicines today announced positive top-line results from its global, randomized, controlled Phase III RASolute 302 ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

Revolution Medicines stock rallies on impressive daraxonrasib Phase 3 results. Here’s why RVMD shares may sustain the ...

We used stock screeners to make a list of biotech stocks under $20 and picked 8 stocks with the highest number of hedge fund ...